- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4/A Registration of securities issued in business combination transactions
- 3.4 Form of Amended and Restated Certificate of Incorporation of Suneva Holdings, Inc
- 3.5 Form of Amended and Restated Bylaws of Suneva Holdings, Inc
- 10.9 Form of 2022 Stock Option and Incentive Plan
- 10.10 Form 2022 Employee Stock Purchase Plan Proposal
- 99.1 Form of Proxy Card
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm of Viveon Health Acquisition Corp
- 23.2 Consent of Cohnreznick LLP, Independent Registered Public Accounting Firm of Suneva Medical Inc
- Download Excel data file
- View Excel data file
- 28 Feb 23 RW Registration withdrawal request
- 23 Nov 22 424B3 Prospectus supplement
- 17 Nov 22 424B3 Prospectus supplement
- 15 Nov 22 EFFECT Notice of effectiveness
- 10 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
3 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 19 Sep 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 13 Jul 22 S-4 Registration of securities issued in business combination transactions
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use of our report dated July 13, 2022 with respect to the financial statements of Suneva Medical, Inc. as of December 31, 2021 and 2020, and for the years then ended, which includes an explanatory paragraph related to Suneva Medical, Inc.’s ability to continue as a going concern, included in this Proxy Statement that is made a part of this Amendment No. 2 to the Registration Statement on Form S-4 and Prospectus of Viveon Health Acquisition Corp. for the registration of 25,258,208 shares of Viveon Health Acquisition Corp. common stock.
We also consent to the reference to our firm under the caption “Experts.”
/s/ CohnReznick LLP
New York, New York
November 2, 2022